Given the suspicion of fusion-type sarcoma, RNA-based next-generation sequencing was performed, which identified a fusion product between CIC exon 20 (NM_015125.4) and FOXO4 exon 2 (NM_005938.4). These findings confirmed the diagnosis of CIC-FOXO4 sarcoma. This evidence concerns the gene FOXO4 and sarcoma.